Sarah Braungart

Sarah Braungart

Auto-generated profile, based on publicly available information

Sarah Braungart

Department of Paediatric Surgery Royal Hospital for Children Glasgow UK

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2020 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
SBSarah Braungart
Sarah Braungart
RCRoss J Craigie
Ross J Craigie
PFPaul Farrelly
Paul Farrelly
PLPaul D Losty
Paul D Losty

13 October 2022 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
SBSarah Braungart
Sarah Braungart
EJEleanor Ca James
Eleanor Ca James
MPMark Powis
Mark Powis
HGHany Gabra
Hany Gabra
CCCclg Surgeons Collaborators
Cclg Surgeons Collaborators
PLPaul D. Losty
Paul D. Losty

4 February 2022 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
SBSarah Braungart
Sarah Braungart
CWCara Williams
Cara Williams
SASuren G. Arul
Suren G. Arul
KBKaterina Bambang
Katerina Bambang
RCRoss James Craigie
Ross James Craigie
MPMark Powis
Mark Powis

6 November 2021 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
SBSarah Braungart
Sarah Braungart
RPRobert Thomas Peters
Robert Thomas Peters
NLNick Lansdale
Nick Lansdale
DWDavid John Wilkinson
David John Wilkinson

6 January 2026 in World Journal of Pediatric Surgery
Verified
Journal Article
Open access
SBSarah Braungart
Sarah Braungart
PLPaul D Losty
Paul D Losty
Neuroblastoma constitutes the most common extracranial solid tumor encountered in children under 5 years of age. The clinical course is highly variable, ranging from spontaneous tumor regression in very young infants to a highly aggressive disease in older children. 5-year survival of > 90% in low and intermediate-risk disease compares to < 60% in those with high-risk neuroblastoma despite recent genetic and clinical advances. Treatment strategies vary significantly in intensity depending on the aggressiveness of disease with surgery playing a pivotal role in the management. A solid understanding of different risk groups, individualized management, and outcomes is important for pediatric surgeons to achieve best outcomes, and provide highest quality advice at the multidisciplinary tumor board meeting. This article offers a narrative update on the diagnosis and management of neuroblastoma in childhood and highlights some of the key controversies in the surgical management of the disease.